Grown Rogue International Inc. Share Price
Stocks
GRIN
CA39986R3045
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Canadian Securities Exchange
01:25:43 17/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 0.5300 CAD | -3.64% |
|
-1.85% | -24.29% |
| Market Cap | 9.68Cr 8.61Cr 7.98Cr 7.26Cr 14Cr 918.96Cr 14Cr 96Cr 38Cr 479.55Cr 36Cr 36Cr 1.53TCr | P/E 2024 |
-12x | P/E 2025 | 71.9x |
|---|---|---|---|---|---|
| Enterprise Value | 11Cr 9.97Cr 9.24Cr 8.41Cr 16Cr 1.06TCr 16Cr 111.04Cr 44Cr 555.32Cr 42Cr 41Cr 1.77TCr | EV / Sales 2024 |
5.45x | EV / Sales 2025 | 4.4x |
| Free-Float |
61.83% | Yield 2024 * |
-
| Yield 2025 | - |
Canadian Securities ExchangeCAD
| Markets | Quality | ||
|---|---|---|---|
Canadian Securities Exchange
| GRIN | Delayed | |
OTC Markets
| GRUSF | Delayed | |
|
Deutsche Boerse AG
| 1VF0 | Delayed |
Last Transcript: Grown Rogue International Inc.
| 1 day | -3.64% | ||
| 1 week | -1.85% | ||
| Current month | -10.17% | ||
| 1 month | -11.67% | ||
| 3 months | -20.90% | ||
| 6 months | +17.78% | ||
| Current year | -24.29% |
| 1 week | 0.52 |  | 0.59 |
| 1 month | 0.52 | | 0.66 |
| Current year | 0.38 | | 0.72 |
| 1 year | 0.38 | | 0.72 |
| 3 years | 0.32 | | 1.15 |
| 5 years | 0.06 | | 1.15 |
| 10 years | 0.06 | | 1.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
J. Strickler
CEO | Chief Executive Officer | 45 | 15/11/2018 |
Sarah Strickler
PRN | Corporate Officer/Principal | - | 01/10/2016 |
| Director of Finance/CFO | 42 | 01/01/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Gledhill
BRD | Director/Board Member | 64 | 15/11/2018 |
J. Strickler
CHM | Chairman | 45 | - |
Ryan Kee
BRD | Director/Board Member | 42 | 01/01/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 21/07/26 | Option | Director | 1,20,000 | 0.0480% | ||
| 21/07/26 | Option | Director | 1,20,000 | 0.0480% | ||
| 21/07/26 | Free | Founder | 10,00,000 | 0.4001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.64% | -1.85% | -8.62% | +47.22% | 9.68Cr | |
| +0.43% | +7.48% | +52.08% | +106.34% | 1,11600Cr | |
| +0.90% | -0.36% | +33.68% | +62.93% | 61TCr | |
| +0.71% | +4.77% | +26.17% | +92.90% | 50TCr | |
| +0.52% | +2.51% | +73.52% | +40.32% | 36TCr | |
| -0.13% | +7.51% | +33.47% | +48.68% | 37TCr | |
| -0.95% | +5.93% | +19.86% | +42.48% | 29TCr | |
| -1.98% | +4.66% | -1.57% | +13.41% | 26TCr | |
| -0.35% | +6.15% | +45.46% | +52.23% | 23TCr | |
| -0.75% | +6.18% | +32.03% | +101.15% | 20TCr | |
| Average | -0.34% | +4.92% | +30.61% | +60.77% | 39.3TCr | |
| Weighted average by Cap. | +0.30% | +4.93% | +38.82% | +72.16% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.7Cr 2.4Cr 2.23Cr 2.03Cr 3.82Cr 256.41Cr 3.88Cr 27Cr 10Cr 133.81Cr 10Cr 9.92Cr 426.56Cr | 3.24Cr 2.88Cr 2.67Cr 2.43Cr 4.59Cr 307.76Cr 4.66Cr 32Cr 13Cr 160.6Cr 12Cr 12Cr 511.98Cr |
| Net income | -1.13Cr -1Cr -93.13L -84.73L -1.6Cr -107.28Cr -1.62Cr -11Cr -4.39Cr -56Cr -4.24Cr -4.15Cr -178.47Cr | 17.3L 15.38L 14.25L 12.97L 24.47L 16Cr 24.86L 1.71Cr 67.17L 8.57Cr 64.92L 63.54L 27Cr |
| Net Debt | 37.04L 32.93L 30.52L 27.77L 52.4L 35Cr 53.24L 3.67Cr 1.44Cr 18Cr 1.39Cr 1.36Cr 58Cr | 1.53Cr 1.36Cr 1.26Cr 1.15Cr 2.16Cr 145.2Cr 2.2Cr 15Cr 5.94Cr 76Cr 5.74Cr 5.62Cr 241.55Cr |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/26/17 | CA$0.5300 | -3.64% | 15,406 |
| 15/26/15 | CA$0.5500 | -3.51% | 29,500 |
| 14/26/14 | CA$0.5700 | +1.79% | 23,092 |
| 13/26/13 | CA$0.5600 | -1.75% | 14,000 |
| 09/26/09 | CA$0.5700 | +5.56% | 7,000 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- GRIN Stock
Select your edition
All financial news and data tailored to specific country editions
